This article is more than 5 years old. Information may no longer be current.

Arthrosurface receives FDA clearance for toe fixation system

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Arthrosurface Inc. received FDA 501(k) clearance for its BOSS toe fixation system, which is intended to improve stabilization in a first metatarsal with a distal bone void.

“Finally, there is an option other than fusion for failed synthetic implants. We can preserve motion of the joint, even in these difficult cases where there is a defect or void in the bone,” Carl Hasselman, MD, an orthopedic surgeon with UPMC in Pennsylvania, said in a company press release.

Arthrosurface’s BOSS toe fixation system is to be used along with the company’s existing line of HemiCAP DF implants and ToeMotion systems to stabilize the joint while protecting the length and mechanical axis of the toe and prevent the need for fusion.

Reference:

www.arthrosurface.com/